Ignite Creation Date:
2024-05-06 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 12:53 PM
Study NCT ID:
NCT03655002
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-30
First Post:
2018-08-29
Brief Title:
IRX-2 Cyclophosphamide and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Organization Data
Organization:
City of Hope Medical Center
Class:
OTHER
Study ID:
18245
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
City of Hope Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |